CRONOS GROUP INC. Operating Lease, Right-of-Use Asset, Amortization Expense
CRONOS GROUP INC. (CRON) reported Operating Lease, Right-of-Use Asset, Amortization Expense of $234.91 million for the 3-month period ending 2021-06-30, per its 10-Q/A filed 2022-02-18.
Discontinued › Cash Flow › Operating Activities
us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense · last filed 2022-02-18
- CRONOS GROUP INC. operating lease, right-of-use asset, amortization expense for the quarter ending 2021-06-30 was $234.91M, a 487.28% increase year-over-year.
- CRONOS GROUP INC. operating lease, right-of-use asset, amortization expense for the quarter ending 2021-03-31 was $1.74M.
- CRONOS GROUP INC. operating lease, right-of-use asset, amortization expense for the quarter ending 2020-06-30 was $40.00M.
| Period end | Operating Lease, Right-of-Use Asset, Amortization Expense 3 month | Operating Lease, Right-of-Use Asset, Amortization Expense 6 month | Operating Lease, Right-of-Use Asset, Amortization Expense 6 month as first filed |
|---|---|---|---|
| 2021-06-30 | $234.91M 10-Q/A · filed 2022-02-18 | $2.96M 10-Q/A · filed 2022-02-18 | $1.74M 10-Q · filed 2021-08-06 |
| 2021-03-31 | $1.74M 10-Q · filed 2021-05-07 | ||
| 2020-06-30 | $40.00M 10-Q · filed 2021-08-06 | $40.00M 10-Q/A · filed 2022-02-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| Canopy Growth Corp (CGC) | $0.395B | ||
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |